Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00233779
Status:
COMPLETED
Last Update Posted:
2007-06-27
First Post:
2005-10-04
Brief Title:
Evaluation of Sirolimus-Eluting Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small VesselsEVOLUTION
Sponsor:
Cordis Corporation
Organization:
Cordis Corporation
Study Overview
Official Title:
Sirolimus-Eluting Heparin-Coated Cobalt Chromium Balloon-Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions in Small Vessels EVOLUTION
Status:
COMPLETED
Status Verified Date:
2007-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to assess the performance and safety of a sirolimus-eluting heparin-coated cobalt chromium balloon-expandable stent Small Vessel Stent in patients with de novo native coronary artery lesions in small vessels as compared to historical data from small vessel patients in the RAVEL trial receiving the Sirolimus-eluting Bx VELOCITY stent
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None